Sfoglia per Autore
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
2005-01-01 Galimberti, Sara; Benedetti, E; Morabito, F; Papineschi, Federico; Callea, V; Fazzi, R; Stelitano, C; Andreazzoli, F; Guerrini, Francesca; Ciabatti, Elena; Martino, M; Nobile, F; Iacopino, P; Petrini, Mario
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation
2006-01-01 Galimberti, Sara; Benedetti, E; Morabito, F; Petrini, Iacopo; Battolla, B; Papineschi, Federico; Fazzi, R; Ciabatti, Elena; Martino, M; Cuzzola, M; Console, G; Iacopino, P; Petrini, Mario
Human mesenchymal cells inhibit IL2 and zoledronate-induced gamma/delta T-cells
2007-01-01 Petrini, Iacopo; Fazzi, R; Pacini, Simone; Galimberti, Sara; Trombi, Luisa; Ciabatti, Elena; Petrini, Mario
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia
2007-01-01 Guerrini, Francesca; Galimberti, Sara; Ciabatti, Elena; Brizzi, S; Testi, Rossana; Pollastrini, A; Falini, B; Petrini, Mario
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen
2007-01-01 Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms
2007-01-01 Galimberti, Sara; Palumbo, Ga; Caracciolo, F; Benedetti, E; Pelosini, M; Brizzi, S; Ciabatti, Elena; Fazzi, R; Stelitano, C; Quintana, G; Conte, E; Tibullo, D; DI RAIMONDO, F; Petrini, Mario
Cell clonality in hypereosinophilic syndrome: what pathogenetic role?
2007-01-01 Galimberti, Sara; Ciabatti, Elena; Ottimo, F; Rossi, ANNA MARIA; Trombi, Luisa; Carulli, Giovanni; Cervetti, G; Mattii, Letizia; Bianchi, G; Petrini, Mario
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma
2007-01-01 Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line
2009-01-01 Galimberti, Sara; Canestraro, Martina; Maffei, R; Marasca, R; Guerrini, Francesca; Piaggi, Simona; Ciabatti, Elena; Petrini, Mario
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes
2010-01-01 Galimberti, Sara; Ghio, Francesco; Guerrini, Francesca; Ciabatti, Elena; Grassi, Susanna; Ferreri, Maria Immacolata; Petrini, Mario
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME
2013-01-01 Galimberti, Sara; Ciabatti, Elena; Grassi, Susanna; Mr, Metelli; Guerrini, Francesca; Paggiaro, PIER LUIGI; S., Bombardieri; Petrini, Mario; Baldini, Chiara
Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.sinensis leaf extract.
2013-01-01 Carulli, Giovanni; Ciancia, Em; Azzarà, A; Ottaviano, V; Grassi, S; Ciabatti, Elena; Ferreri, Mi; Rocco, M; Marini, A; Petrini, Mario
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT.
2013-01-01 Galimberti, Sara; M., Rocco; T., Mingrone; Ciabatti, Elena; Grassi, Susanna; Guerrini, Francesca; Mr, Metelli; G., Cervetti; N., Cecconi; F., Ghio; R., Fazzi; Azzara', Antonio; Petrini, Mario
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA
2013-01-01 Galimberti, Sara; Polillo, Marialuisa; M., Capecchi; G., Cervetti; C., Baratè; Guerrini, Francesca; Fontanelli, Giulia; Arici, Roberta; Ciabatti, Elena; Grassi, Susanna; Bocci, Guido; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance
2014-01-01 Della Starza, I.; Cavalli, M.; Del Giudice, I.; Barbero, D.; Mantoan, B.; Genuardi, E.; Urbano, M.; Mannu, C.; Gazzola, A.; Ciabatti, Elena; Guarini, A.; Foa, R.; Galimberti, Sara; Piccaluga, P.; Gaidano, G.; Ladetto, M.; Monitillo, L.
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification
2014-01-01 Ciabatti, Elena; Mi, Ferreri; A., Valetto; A., Guazzelli; V., Bertini; Grassi, Susanna; Guerrini, Francesca; A., Azzarà; Mr, Metelli; Petrini, Iacopo; P., Simi; Petrini, Mario; Galimberti, Sara
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms
2014-01-01 Fontanelli, Giulia; C., Baratè; Ciabatti, Elena; Guerrini, Francesca; R., Morganti; Arici, Roberta; S., Barsotti; Petrini, Iacopo; DEL RE, Marzia; Petrini, Mario; Galimberti, Sara
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment.
2014-01-01 Galimberti, Sara; Galeotti, L; Ceccherini, F; Laurino, M; Cornolti, Fulvio; Guerrini, Francesca; Ciabatti, Elena; Grassi, S; Baratè, C; Fontanelli, G; Barsotti, S; Ricci, F; Arici, Roberta; Petrini, Mario; Polillo, Ml; DI PAOLO, Antonello
No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan
2014-01-01 Focosi, Daniele; Macera, L.; Ciabatti, Elena; Galimberti, Sara; Petrini, Mario; Carella, Am; Pistello, Mauro; CECCHERINI-NELLI, Luca; Maggi, Fabrizio
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial
2014-01-01 Galimberti, Sara; Luminari, Stefano; Ciabatti, Elena; Grassi, Susanna; Guerrini, Francesca; Dondi, Alessra; Marcheselli, Luigi; Ladetto, Marco; Piccaluga, Pier Paolo; Gazzola, Anna; Mannu, Claudia; Monitillo, Luigia; Mantoan, Barbara; Giudice, Ilaria Del; Starza, Irene Della; Cavalli, Marzia; Arcaini, Luca; Tucci, Alessra; Palumbo, Giuseppe Alberto; Rigacci, Luigi; Pulsoni, Alessro; Vitolo, Umberto; Boccomini, Carola; Vallisa, Daniele; Bertoldero, Giovanni; Gaidano, Gianluca; Musto, Pellegrino; Petrini, Mario; Federico, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation | 1-gen-2005 | Galimberti, Sara; Benedetti, E; Morabito, F; Papineschi, Federico; Callea, V; Fazzi, R; Stelitano, C; Andreazzoli, F; Guerrini, Francesca; Ciabatti, Elena; Martino, M; Nobile, F; Iacopino, P; Petrini, Mario | |
| Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation | 1-gen-2006 | Galimberti, Sara; Benedetti, E; Morabito, F; Petrini, Iacopo; Battolla, B; Papineschi, Federico; Fazzi, R; Ciabatti, Elena; Martino, M; Cuzzola, M; Console, G; Iacopino, P; Petrini, Mario | |
| Human mesenchymal cells inhibit IL2 and zoledronate-induced gamma/delta T-cells | 1-gen-2007 | Petrini, Iacopo; Fazzi, R; Pacini, Simone; Galimberti, Sara; Trombi, Luisa; Ciabatti, Elena; Petrini, Mario | |
| Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia | 1-gen-2007 | Guerrini, Francesca; Galimberti, Sara; Ciabatti, Elena; Brizzi, S; Testi, Rossana; Pollastrini, A; Falini, B; Petrini, Mario | |
| Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen | 1-gen-2007 | Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario | |
| The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms | 1-gen-2007 | Galimberti, Sara; Palumbo, Ga; Caracciolo, F; Benedetti, E; Pelosini, M; Brizzi, S; Ciabatti, Elena; Fazzi, R; Stelitano, C; Quintana, G; Conte, E; Tibullo, D; DI RAIMONDO, F; Petrini, Mario | |
| Cell clonality in hypereosinophilic syndrome: what pathogenetic role? | 1-gen-2007 | Galimberti, Sara; Ciabatti, Elena; Ottimo, F; Rossi, ANNA MARIA; Trombi, Luisa; Carulli, Giovanni; Cervetti, G; Mattii, Letizia; Bianchi, G; Petrini, Mario | |
| Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma | 1-gen-2007 | Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario | |
| Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line | 1-gen-2009 | Galimberti, Sara; Canestraro, Martina; Maffei, R; Marasca, R; Guerrini, Francesca; Piaggi, Simona; Ciabatti, Elena; Petrini, Mario | |
| WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes | 1-gen-2010 | Galimberti, Sara; Ghio, Francesco; Guerrini, Francesca; Ciabatti, Elena; Grassi, Susanna; Ferreri, Maria Immacolata; Petrini, Mario | |
| TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME | 1-gen-2013 | Galimberti, Sara; Ciabatti, Elena; Grassi, Susanna; Mr, Metelli; Guerrini, Francesca; Paggiaro, PIER LUIGI; S., Bombardieri; Petrini, Mario; Baldini, Chiara | |
| Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.sinensis leaf extract. | 1-gen-2013 | Carulli, Giovanni; Ciancia, Em; Azzarà, A; Ottaviano, V; Grassi, S; Ciabatti, Elena; Ferreri, Mi; Rocco, M; Marini, A; Petrini, Mario | |
| R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. | 1-gen-2013 | Galimberti, Sara; M., Rocco; T., Mingrone; Ciabatti, Elena; Grassi, Susanna; Guerrini, Francesca; Mr, Metelli; G., Cervetti; N., Cecconi; F., Ghio; R., Fazzi; Azzara', Antonio; Petrini, Mario | |
| THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA | 1-gen-2013 | Galimberti, Sara; Polillo, Marialuisa; M., Capecchi; G., Cervetti; C., Baratè; Guerrini, Francesca; Fontanelli, Giulia; Arici, Roberta; Ciabatti, Elena; Grassi, Susanna; Bocci, Guido; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello | |
| Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance | 1-gen-2014 | Della Starza, I.; Cavalli, M.; Del Giudice, I.; Barbero, D.; Mantoan, B.; Genuardi, E.; Urbano, M.; Mannu, C.; Gazzola, A.; Ciabatti, Elena; Guarini, A.; Foa, R.; Galimberti, Sara; Piccaluga, P.; Gaidano, G.; Ladetto, M.; Monitillo, L. | |
| Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification | 1-gen-2014 | Ciabatti, Elena; Mi, Ferreri; A., Valetto; A., Guazzelli; V., Bertini; Grassi, Susanna; Guerrini, Francesca; A., Azzarà; Mr, Metelli; Petrini, Iacopo; P., Simi; Petrini, Mario; Galimberti, Sara | |
| Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms | 1-gen-2014 | Fontanelli, Giulia; C., Baratè; Ciabatti, Elena; Guerrini, Francesca; R., Morganti; Arici, Roberta; S., Barsotti; Petrini, Iacopo; DEL RE, Marzia; Petrini, Mario; Galimberti, Sara | |
| Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. | 1-gen-2014 | Galimberti, Sara; Galeotti, L; Ceccherini, F; Laurino, M; Cornolti, Fulvio; Guerrini, Francesca; Ciabatti, Elena; Grassi, S; Baratè, C; Fontanelli, G; Barsotti, S; Ricci, F; Arici, Roberta; Petrini, Mario; Polillo, Ml; DI PAOLO, Antonello | |
| No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan | 1-gen-2014 | Focosi, Daniele; Macera, L.; Ciabatti, Elena; Galimberti, Sara; Petrini, Mario; Carella, Am; Pistello, Mauro; CECCHERINI-NELLI, Luca; Maggi, Fabrizio | |
| Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial | 1-gen-2014 | Galimberti, Sara; Luminari, Stefano; Ciabatti, Elena; Grassi, Susanna; Guerrini, Francesca; Dondi, Alessra; Marcheselli, Luigi; Ladetto, Marco; Piccaluga, Pier Paolo; Gazzola, Anna; Mannu, Claudia; Monitillo, Luigia; Mantoan, Barbara; Giudice, Ilaria Del; Starza, Irene Della; Cavalli, Marzia; Arcaini, Luca; Tucci, Alessra; Palumbo, Giuseppe Alberto; Rigacci, Luigi; Pulsoni, Alessro; Vitolo, Umberto; Boccomini, Carola; Vallisa, Daniele; Bertoldero, Giovanni; Gaidano, Gianluca; Musto, Pellegrino; Petrini, Mario; Federico, Massimo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile